DNA strand cleavage by the phenazine di- N -oxide natural product myxin under both aerobic and anaerobic conditions

Chemical Research in Toxicology

Volumn 25, Issue 1, 2012, Pages 197-206

  Chowdhury, Goutam ^a   Sarkar, Ujjal ^a   Pullen, Susan ^b   Wilson, William R ^b   Rajapakse, Anuruddha ^a   Fuchs Knotts, Tarra ^a   Gates, Kent S ^a  

^a UNIVERSITY OF MISSOURI   (United States)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

HETEROCYCLIC N OXIDE; MYXIN; NATURAL PRODUCT; OXIDE; OXYGEN; TIRAPAZAMINE; UNCLASSIFIED DRUG;

AEROBIC CELL CULTURE; ANAEROBIC CELL CULTURE; ANTIMICROBIAL ACTIVITY; ARTICLE; BIOLOGICAL ACTIVITY; CANCER CELL CULTURE; CELL KILLING; COLORECTAL CANCER; CYTOTOXICITY; DNA CLEAVAGE; DNA DAMAGE; DNA STRAND; ENZYME METABOLISM; HUMAN; HUMAN CELL; HYPOXIA;

AEROBIOSIS; ANAEROBIOSIS; ANTINEOPLASTIC AGENTS; BIOLOGICAL AGENTS; CELL LINE, TUMOR; DNA CLEAVAGE; HUMANS; OXIDATION-REDUCTION; PHENAZINES; TRIAZINES;

SORANGIUM;

EID: 84855834317     PISSN: 0893228X     EISSN: 15205010     Source Type: Journal    
DOI: 10.1021/tx2004213     Document Type: Article

References (84)

1. Xia, Q., Zhang, L., Zhang, J., Sheng, R., Yang, B., He, Q., and Hu, Y. (2011) Synthesis, hypoxia-selective cytotoxicity of new 3-amino-1,2,4- benzotriazine 1,4-dioxide derivatives Eur. J. Med. Chem. 46, 919-926
2. Ismail, M. M. F., Amin, K. M., Naoman, E., Soliman, D. H., and Ammar, Y. A. (2010) New quinoxaline 1,4-dioxides: anticancer and hypoxia-selective agents Eur. J. Med. Chem. 45, 2733-2738
3. Lavaggi, M. L., Cabrera, M., González, M., and Cerecetto, H. (2008) Differential enzymatic reductions governing the differential hypoxia-selective cytotoxicities of phenazine 5,10-dioxides Chem. Res. Toxicol. 21, 1900-1906
4. Hicks, K. O., Siim, B. G., Jaiswal, J. K., Pruijin, F. B., Fraser, A. M., Patel, R., Hogg, A., Liyanage, H. D. S., Dorie, M. J., Brown, J. M., Denny, W. A., Hay, M. P., and Wilson, W. R. (2010) Pharmacokinetic/pharmacodynamic modeling identifies SN30000 and SN29751 as tirapazamine analogues with improved tissue penetration and hypoxic cell killing in tumors Clin. Cancer Res. 16, 4946-4957
5. Hay, M. P., Gamage, S. A., Kovacs, M. S., Pruijn, F. B., Anderson, R. F., Patterson, A. V., Wilson, W. R., Brown, J. M., and Denny, W. A. (2003) Structure-activity relationships of 1,2,4-benzotriazine 1,4-dioxides as hypoxia-selective analogues of tirapazamine J. Med. Chem. 46, 169-182 (Pubitemid 36043797)
6. Hay, M. P., Hicks, K. O., Pchalek, K., Lee, H. H., Blaser, A., Pruijn, F. B., Anderson, R. F., Shinde, S. S., Wilson, W. R., and Denny, W. A. (2008) Tricyclic [1,2,4]triazine 1,4-dioxides as hypoxia selective cytotoxins J. Med. Chem. 51, 6853-6865
7. Solano, B., Junnotula, V., Marin, A., Villar, R., Burguete, A., Vicente, E., Perez-Silanes, S., Monge, A., Dutta, S., Sarkar, U., and Gates, K. S. (2007) Synthesis and biological evaluation of new 2-arylcarbonyl-3- trifluoromethylquinoxaline 1,4-dioxide derivatives and their reduced analogues J. Med. Chem. 50, 5485-5492 (Pubitemid 350057858)
8. Wilson, W. R. and Hay, M. P. (2011) Targeting hypoxia in cancer therapy Nat. Rev. Cancer 11, 393-409
9. Marcu, L. and Olver, I. (2006) Tirapazamine: from the bench to clinical trials Curr. Clin. Oncol. 1, 71-79
10. 18F]- misonidazole positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine: a substudy of Trans-Tasman Radiation Oncology Group Study 98.02 J. Clin. Oncol. 24, 2098-2104 (Pubitemid 46622121)
11. Rischin, D., Peters, L. J., O'Sullivan, B., Giralt, J., Fisher, R., Yuen, K., Trotti, A., Bernier, J., Bourhis, J., Ringash, J., Henke, M., and Kenny, L. (2010) Tirapazamine, cisplatin, and radiation versus cisplatin and radiation for advanced squamous cell carcinoma of the head and neck (TROG 02.02, HeadSTART): a phase III trial of the trans-tasman radiation oncology group J. Clin. Oncol. 28, 2989-2995
12. Vicente, E., Villar, R., Burguete, A., Solano, B., Pérez-Silanes, S., Aldana, I., Maddry, J. A., Lenaerts, A. J., Franzblau, S. G., Cho, S.-h., Monge, A., and Goldman, R. C. (2008) Efficacy of quinoxaline-2-carboxylate 1,4-di-N-oxide derivatives in experimental tuberculosis Antimicrob. Agents Chemother. 52, 3321-3326
13. Ganley, B., Chowdhury, G., Bhansali, J., Daniels, J. S., and Gates, K. S. (2001) Redox-activated, hypoxia-selective DNA cleavage by quinoxaline 1,4-di-N-oxide Bioorg. Med. Chem. 9, 2395-2401 (Pubitemid 32834628)
14. McIlwain, H. (1943) Bacterial inhibition by metabolite analogues. Part V. Reactions and antibacterial properties of p -diazine di-N-oxides J. Chem. Soc. part I) 322-327
15. Hennessey, T. D. and Edwards, J. R. (1972) Antibacterial properties of quindoxin: a new growth promoting agent Vet. Rec. 90, 187-190
16. Suter, W., Rosselet, A., and Knusel, F. (1978) Mode of action of quindoxin and substituted quinoxaline-di- N -oxides on E. coli Antimicrob. Agents Chemother. 13, 770-783 (Pubitemid 8323547)
17. Priyadarsini, K. I., Tracy, M., and Wardman, P. (1996) The one-electron reduction potential of 3-amino-1,2,4-benzotriazine 1,4-dioxide (tirapazamine): A hypoxia-selective bioreductive drug Free Radical Res. 25, 393-399 (Pubitemid 26379055)
18. Lloyd, R. V., Duling, D. R., Rumyantseva, G. V., Mason, R. P., and Bridson, P. K. (1991) Microsomal reduction of 3-amino-1,2,4,-benzotriazine 1,4-dioxide to a free radical Mol. Pharmacol. 40, 440-445
19. Wardman, P., Priyadarsini, K. I., Dennis, M. F., Everett, S. A., Naylor, M. A., Patel, K. B., Stratford, I. J., Stratford, M. R. L., and Tracy, M. (1996) Chemical properties which control selectivity and efficacy of aromatic N-oxide bioreductive drugs Br. J. Cancer 74, S70-S74
20. Laderoute, K. L., Wardman, P., and Rauth, M. (1988) Molecular mechanisms for the hypoxia-dependent activation of 3-amino-1,2,4-benzotriazine 1,4-dioxide (SR4233) Biochem. Pharmacol. 37, 1487-1495 (Pubitemid 18093342)
21. Silva, J. M. and O'Brien, P. J. (1993) Molecular mechanisms of SR 4233-induced hepatocyte toxicity under aerobic versus hypoxic conditions Br. J. Cancer 68, 484-491 (Pubitemid 23258450)
22. Laderoute, K. and Rauth, A. M. (1986) Identification of two major reduction products of the hypoxic cell toxin 3-amino-1,2,4-benzotriazine-1,4- dioxide Biochem. Pharmacol. 35, 3417-3420 (Pubitemid 16001459)
23. Walton, M. I. and Workman, P. (1993) Pharmacokinetics and bioreductive metabolism of the novel benzotriazine di- N -oxide hypoxic cell cytotoxin tirapazamine (WIN 59075, SR 4233, NSC 130181) in mice J. Pharmacol. Exp. Ther. 265, 938-947 (Pubitemid 23315608)
24. Zeman, E. M., Brown, J. M., Lemmon, M. J., Hirst, V. K., and Lee, W. W. (1986) SR 4233: a new bioreductive agent with high selective toxicity for hypoxic mammalian cells Int. J. Radiat. Oncol. Biol. Phys. 12, 1239-1242 (Pubitemid 16055893)
25. Zeman, E. M., Baker, M. A., Lemmon, M. J., Pearson, B. A., Adams, J. A., Brown, J. M., Lee, W. W., and Tracy, M. (1989) Structure-activity relationships for benzotriazine di-N-oxides Int. J. Radiat. Oncol. Biol. Phys 16, 977-981 (Pubitemid 19154285)
26. Brown, J. M. (1993) SR4233 (Tirapazamine): a new anticancer drug exploiting hypoxia in solid tumours Br. J. Cancer 67, 1163-1170 (Pubitemid 23172847)
27. Evans, J. W., Chernikova, S. B., Kachnic, L. A., Banath, J. P., Sordet, O., Delahoussaye, Y. M., Treszezamsky, A., Chon, B. H., Feng, Z., Gu, Y., Wilson, W. R., Pommier, Y., Olive, P. L., Powell, S. N., and Brown, J. M. (2008) Homologous recombination is the principal pathway for the repair of DNA damage induced by tirapazamine in mammalian cells Cancer Res. 68, 257-265 (Pubitemid 351380127)
28. Birincioglu, M., Jaruga, P., Chowdhury, G., Rodriguez, H., Dizdaroglu, M., and Gates, K. S. (2003) DNA base damage by the antitumor agent 3-amino-1,2,4-benzotriazine 1,4-dioxide (tirapazamine) J. Am. Chem. Soc. 125, 11607-11615 (Pubitemid 37210109)
29. Daniels, J. S. and Gates, K. S. (1996) DNA cleavage by the antitumor agent 3-amino-1,2,4-benzotriazine 1,4-dioxide (SR4233): evidence for involvement of hydroxyl radical J. Am. Chem. Soc. 118, 3380-3385 (Pubitemid 26145092)
30. Junnotula, V., Sarkar, U., Sinha, S., and Gates, K. S. (2009) Initiation of DNA strand cleavage by 1,2,4-benzotriazine 1,4-dioxides: mechanistic insight from studies of 3-methyl-1,2,4-benzotriazine 1,4-dioxide J. Am. Chem. Soc. 131, 1015-1024
31. 2 J. Am. Chem. Soc. 129, 12870-12877 (Pubitemid 350004499)
32. Shinde, S. S., Anderson, R. F., Hay, M. P., Gamage, S. A., and Denny, W. A. (2004) Oxidation of 2-deoxyribose by benzotriazinyl radicals of antitumor 3-amino-1,2,4-benzotriazine 1,4-dioxides J. Am. Chem. Soc. 126, 7865-7874 (Pubitemid 38812777)
33. Shinde, S. S., Hay, M. P., Patterson, A. V., Denny, W. A., and Anderson, R. F. (2009) Spin trapping of radicals other than the hydroxyl radical upon reduction of the anticancer agent tirapazamine by cytochrome P450 reductase J. Am. Chem. Soc. 131, 14220-14221
34. Shinde, S. S., Maroz, A., Hay, M. P., Patterson, A. V., Denny, W. A., and Anderson, R. F. (2010) Characterization of radicals formed following enzymatic reduction of 3-substituted analogues of the hypoxia-selective cytotoxin 3-amino-1,2,4-benzotriazine 1,4-dioxide (tirapazamine) J. Am. Chem. Soc. 132, 2591-2599
35. Anderson, R. F., Shinde, S. S., Hay, M. P., Gamage, S. A., and Denny, W. A. (2003) Activation of 3-amino-1,2,4-benzotriazine 1,4-dioxide antitumor agents to oxidizing species following their one-electron Reduction J. Am. Chem. Soc. 125, 748-756 (Pubitemid 36109936)
36. Anderson, R. F., Shinde, S. S., Hay, M. P., Gamage, S. A., and Denny, W. A. (2005) Radical properties governing the hypoxia-selective cytotoxicity of antitumor 3-amino-1,2,4-benzotriazine 1,4-dioxides Org. Biomol. Chem. 3, 2167-2174 (Pubitemid 40859896)
37. Fuchs, T., Chowdhary, G., Barnes, C. L., and Gates, K. S. (2001) 3-Amino-1,2,4-benzotriazine 4-oxide: characterization of a new metabolite arising from bioreductive processing of the antitumor agent 3-amino-1,2,4- benzotriazine 1,4-dioxide (tirapazamine) J. Org. Chem. 66, 107-114 (Pubitemid 32057846)
38. Terao, M. (1963) On a new antibiotic, emimycin. II. On the structure of emimycin J. Antibiot. (Tokyo), Sec. A 16, 182-186
39. Ohmoto, T., Tanaka, R., and Nikaido, T. (1976) Studies on the constituents of Ailanthus altissima Swingle. On the alkaloidal constituents Chem. Pharm. Bull. 24, 1532-1536
40. Antkowiak, W. Z. and Gessner, W. P. (1979) The structure of orellanine and orelline Tetrahedron Lett. 20, 1931-1934
41. O'Donnell, G., Poeschl, R., Zimhony, O., Gunaratnam, M., Moreira, J. B. C., Neidle, S., Evangelopoulos, D., Bhakta, S., Malkinson, J. P., Boshoff, H. I., Lenaerts, A., and Gibbons, S. (2009) Bioactive pyridine- N -oxide disulfides from Allium stipitatum J. Nat. Prod. 72, 360-365
42. Nicholas, G. M., Blunt, J. W., and Munro, M. H. G. (2001) Cortamidine oxide, a novel disulfide metabolite from the New Zealand Basidiomycete (mushroom) Cortinarius species J. Nat. Prod. 64, 341-344 (Pubitemid 32249799)
43. Nishioka, H., Imoto, M., Imaoka, T., Sawa, T., Takeuchi, T., and Umezawa, K. (1994) Antitumor effect of piericidin B1 N -oxide J. Antibiot. 47, 447-452
44. Peterson, E. A., Gillespie, D. C., and Cook, F. D. (1966) A wide spectrum antibiotic produced by a species of Sorangium Can. J. Microbiol. 12, 221-230
45. Weigele, M., Maestrone, G., Mitrovic, M., and Leimgruber, W. (1970) Antimicrobial agents structurally related to myxin Antimicrob. Agents Chemother. 10, 46-49
46. Lesley, S. M. and Behki, R. M. (1973) Sensitivity to myxin of Escherichia coli treated with ethylenediaminetetraacetic acid Can. J. Microbiol. 19, 531-533
47. Lavaggi, M. L., Cabrera, M., de los Ángeles Aravena, M., Olea-Azar, C., Lopez de Cerain, A., Monge, A., Pachon, G., Cascante, M., Bruno, A. M., Pietrasanta, L. I., Gonzalez, M., and Cerecetto, H. (2010) Study of benzo[a]phenazine 7,12-dioxide as selective hypoxic cytotoxin-scaffold. Identification of aerobic-antitumoral activity through DNA fragmentation Bioorg. Med. Chem. 18, 4433-4440
48. Behki, R. M. and Lesley, S. M. (1972) Deoxyribnucleic acid degradation and the lethal effect by myxin in E. coli J. Bacteriol. 109, 250-261
49. Hollstein, U. and Butler, P. L. (1972) Inhibition of ribonucleic acid synthesis by myxin Biochemistry 11, 1345-1350
50. Hartman, P. E., Berger, H., and Hartman, Z. (1973) Comparison of hycanthone(Etrenol), some hycanthone analogs, myxin, and 4-nitroquinoline 1-oxide as frameshift mutagens J. Pharmacol. Exp. Ther. 186, 390-398
51. Hollstein, U. and Van Gemert, R. J. J. (1971) Interaction of phenazines with polydeoxyribonucleotides Biochemistry 10, 497-504
52. Lesley, S. M. and Behki, R. M. (1967) Mode of action of myxin on Escherichia coli J. Bacteriol. 94, 1837-1845
53. Pachter, I. J. and Kloetzel, M. C. (1951) The Wohl-Aue reaction. I. Structure of benzo [a] phenazine oxides and syntheses of 1,6-dimethoxyphenazine and 1,6-dichlorophenazine J. Am. Chem. Soc. 73, 4958-4961
54. Weigele, M. and Leimgruber, W. (1967) The structure of myxin Tetrahedron Lett. 8, 715-718
55. Edwards, O. E. and Gillespie, D. C. (1966) N-Dioxides, a new class of amine oxides Tetrahedron Lett. 40, 4867-4870
56. Bauer, W. and Vinograd, J. (1968) The interaction of closed circular DNA with intercalative dyes. I. The superhelix density of SV40 DNA in the presence and absence of dye J. Mol. Biol. 33, 141-171
57. Skehan, P., Storeng, R., Scudiero, D., Monks, A., McMahon, J., Vistica, D., Warren, J. T., Bokesch, H., Kenney, S., and Boyd, M. R. (1990) New colorimetric cytotoxicity assay for anticancer-drug screening J. Natl. Cancer Inst. 82, 1107-1112 (Pubitemid 20213250)
58. Wohl, A. and Aue, W. (1901) Über die Einwirkung von Nitrobenzol auf Anilin bei Gegenwart von Alkali Chem. Ber. 34, 2442-2450
59. Clemo, G. R. and Daglish, A. F. (1950) The constitution of the pigment of Chromobacterium iodinum J. Chem. Soc. 1481-1485
60. Jonson, P. H. and Grossman, L. I. (1977) Electrophoresis of DNA in agarose gels. Optimizing separations of conformational isomers of double and single-stranded DNAs Biochemistry 16, 4217-4224
61. Mirabelli, C. K., Huang, C. H., Fenwick, R. G., and Crooke, S. T. (1985) Quantitative measurement of single- and double-strand breakage of DNA in Escherichia coli by the antitumor antibiotics bleomycin and talisomycin Antimicrob. Agents Chemother. 27, 460-467 (Pubitemid 15097639)
62. Oppenheim, A. (1981) Separation of closed circular DNA from linear DNA by electrophoresis in two dimensions in agarose gels Nucleic Acids Res. 9, 6805-6812
63. Hintermann, G., Fischer, H. M., Crameri, R., and Hutter, R. (1981) Simple procedure for distinguishing CCC, OC, and L forms of plasmid DNA by agarose gel electrophoresis Plasmid 5, 371-373 (Pubitemid 11035706)
64. Jones, G. D. D. and Weinfeld, M. (1996) Dual action of tirapazamine in the induction of DNA strand breaks Cancer Res. 56, 1584-1590 (Pubitemid 26104022)
65. Chowdhury, G., Kotandeniya, D., Barnes, C. L., and Gates, K. S. (2004) Enzyme-activated, hypoxia-selective DNA damage by 3-amino-2- quinoxalinecarbonitrile 1,4-di-N-oxide Chem. Res. Toxicol. 17, 1399-1405 (Pubitemid 39532308)
66. Junnotula, V., Rajapakse, A., Abrillaga, L., Lopez de Cerain, A., Solano, B., Villar, R., Monge, A., and Gates, K. S. (2010) DNA strand cleaving properties and hypoxia-selective cytotoxicity of 7-chloro-2-thienylcarbonyl-3- trifluoromethylquinoxaline 1,4-dioxide Bioorg. Med. Chem. 18, 3125-3132
67. Fuchs, T., Gates, K. S., Hwang, J.-T., and Greenberg, M. M. (1999) Photosensitization of guanine-specific DNA damage by a cyano-substituted quinoxaline di- N -oxide Chem. Res. Toxicol. 12, 1190-1194 (Pubitemid 30013529)
68. Daniels, J. S., Chatterji, T., MacGillivray, L. R., and Gates, K. S. (1998) Photochemical DNA cleavage by the antitumor agent 3-amino-1,2,4- benzotriazine 1,4-dioxide (Tirapazamine, WIN 59075, SR4233) J. Org. Chem. 63, 10027-10030 (Pubitemid 29035172)
69. Rastelli, G., Costantino, L., and Albasini, A. (1997) A model of the interaction of substrates and inhibitors with xanthine oxidase J. Am. Chem. Soc. 119, 3007-3016 (Pubitemid 27204515)
70. McCormack, J. J., Allen, B. A., and Hodnett, C. N. (1978) Oxidation of quinazoline and quinoxaline by xanthine oxidase and aldehyde oxidase J. Heterocyclic Chem. 15, 1249-1254 (Pubitemid 9104810)
71. Krenitsky, T. A., Neil, S. M., Elion, G. B., and Hitchings, G. H. (1972) A comparison of the specificities of xanthine oxidase and aldehyde oxidase Arch. Biochem. Biophys. 150, 585-599
72. Brawn, K. and Fridovich, I. (1981) DNA strand scission by enzymatically generated oxygen radicals Arch. Biochem. Biophys. 206, 414-419
73. Halliwell, B. and Gutteridge, J. M. C. (1990) Role of free radicals and catalytic metal ions in human disease: an overview Methods Enzymol. 186, 1-85 (Pubitemid 20279941)
74. Nakamura, M. (1991) Allopurinol-insensitive oxygen radical formation by milk xanthine oxidase systems J. Biochem. 110, 450-456
75. Yee, S. B. and Pritsos, C. A. (1997) Comparison of oxygen radical generation from the reductive activation of doxorubicin, streptonigrin, and menadione by xanthine oxidase and xanthine dehydrogenase Arch. Biochem. Biophys. 347, 235-241 (Pubitemid 27492794)
76. Donahue, J. J. and Oliveri-Vigh, S. (1973) Electrochemical characterization of 6-methoxy-1-phenazinol-5,10-dioxide Anal. Chim. Acta 63, 415-425
77. Daniels, J. S., Gates, K. S., Tronche, C., and Greenberg, M. M. (1998) Direct evidence for bimodal DNA damage induced by tirapazamine Chem. Res. Toxicol. 11, 1254-1257 (Pubitemid 28531544)
78. Hwang, J.-T., Greenberg, M. M., Fuchs, T., and Gates, K. S. (1999) Reaction of the hypoxia-selective antitumor agent tirapazamine with a C1′-radical in single-stranded and double-stranded DNA: the drug and its metabolites can serve as surrogates for molecular oxygen in radical-mediated DNA damage reactions Biochemistry 38, 14248-14255
79. Forconi, M. and Williams, N. H. (2002) Mimicking metallophosphatases: revealing a role for an OH group with no libido Angew. Chem., Int. Ed. Engl. 41, 849-852 (Pubitemid 34218544)
80. Lavaggi, M. L., Cabrera, M., Pintos, C., Arredondo, C., Pachón, G., Robríquez, J., Raymondo, S., Pacheco, J. P., Cascante, M., Olea-Azar, C., López de Cerain, A., Monge, A., Cerecetto, H., and González, M. (2011) Novel phenazine 5,10-dioxides release •OH in simulated hypoxia and induce reduction of tumour volume in vivo ISRN Pharmacol. 10.5402/2011/314209
81. Minisci, F., Punta, C., Recupero, F., Fontana, F., and Pedulli, G. F. (2002) Aerobic oxidation of N-alkylamides catalyzed by N-hydroxyphthalimide under mild conditions. Polar and enthalic effects J. Org. Chem. 67, 2671-2676 (Pubitemid 34298884)
82. Hunter, E. P. L, Derosiers, M. F., and Simic, M. G. (1989) The effect of oxygen, antioxidants, and superoxide radical on tyrosine phenoxyl radical dimerization Free Radical Biol. Med. 6, 581-585 (Pubitemid 19147807)
83. Guengerich, F. P. (2001) Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity Chem. Res. Toxicol. 14, 611-650 (Pubitemid 32565712)
84. Hertzberg, R. P. and Dervan, P. B. (1984) Cleavage of DNA with methidiumpropyl-EDTA-Iron(II): Reaction conditions and product analyses Biochemistry 23, 3934-3945